90 related articles for article (PubMed ID: 16818283)
21. Evidence for deletion of 9q as a two-step process in chronic myeloid leukemia.
Rudduck-Sivaswaren C; Tien SL; Lim P; Lim E; Lie DK; Tan PH; Lee AS
Clin Genet; 2005 Nov; 68(5):461-5. PubMed ID: 16207215
[TBL] [Abstract][Full Text] [Related]
22. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
[TBL] [Abstract][Full Text] [Related]
24. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
25. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
[TBL] [Abstract][Full Text] [Related]
26. Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements.
De Melo VA; Milojkovic D; Marin D; Apperley JF; Nacheva EP; Reid AG
Cancer Genet Cytogenet; 2008 Apr; 182(2):111-5. PubMed ID: 18406872
[TBL] [Abstract][Full Text] [Related]
27. Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
Castagnetti F; Testoni N; Luatti S; Marzocchi G; Mancini M; Kerim S; Giugliano E; Albano F; Cuneo A; Abruzzese E; Martino B; Palandri F; Amabile M; Iacobucci I; Alimena G; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G
J Clin Oncol; 2010 Jun; 28(16):2748-54. PubMed ID: 20439635
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of der(9q) deletions detected through dual-fusion fluorescence in situ hybridization in patients with chronic myeloid leukemia.
Vaz de Campos MG; Montesano FT; Rodrigues MM; Chauffaille Mde L
Cancer Genet Cytogenet; 2007 Oct; 178(1):49-56. PubMed ID: 17889708
[TBL] [Abstract][Full Text] [Related]
29. Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome.
Kolomietz E; Marrano P; Yee K; Thai B; Braude I; Kolomietz A; Chun K; Minkin S; Kamel-Reid S; Minden M; Squire JA
Leukemia; 2003 Jul; 17(7):1313-23. PubMed ID: 12835719
[TBL] [Abstract][Full Text] [Related]
30. Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients.
Storlazzi CT; Specchia G; Anelli L; Albano F; Pastore D; Zagaria A; Rocchi M; Liso V
Genes Chromosomes Cancer; 2002 Nov; 35(3):271-6. PubMed ID: 12353269
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9.
Lundán T; Volin L; Ruutu T; Knuutila S; Porkka K
Leukemia; 2005 Jan; 19(1):138-40. PubMed ID: 15510201
[No Abstract] [Full Text] [Related]
32. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
Kokate P; Dalvi R; Mandava S
J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
[TBL] [Abstract][Full Text] [Related]
33. Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia.
Reid AG; Nacheva EP
Genes Chromosomes Cancer; 2005 Jun; 43(2):223-4; author reply 225. PubMed ID: 15751036
[No Abstract] [Full Text] [Related]
34. MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia.
Chaubey A; Karanti S; Rai D; Oh T; Adhvaryu SG; Aguiar RC
Leukemia; 2009 Jan; 23(1):186-8. PubMed ID: 18548097
[No Abstract] [Full Text] [Related]
35. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
[TBL] [Abstract][Full Text] [Related]
36. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
[TBL] [Abstract][Full Text] [Related]
37. [Molecular biology of chronic myeloid leukemia].
Hellmann A
Acta Haematol Pol; 1992; 23(2 Suppl 1):13-7. PubMed ID: 1488867
[TBL] [Abstract][Full Text] [Related]
38. Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9).
Albano F; Anelli L; Zagaria A; Pannunzio A; Liso V; Rocchi M; Specchia G
Leukemia; 2009 Apr; 23(4):813-6. PubMed ID: 18987658
[No Abstract] [Full Text] [Related]
39. e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia.
Roti G; La Starza R; Gorello P; Gottardi E; Crescenzi B; Martelli MF; Mecucci C
Haematologica; 2005 Aug; 90(8):1139-41. PubMed ID: 16079118
[TBL] [Abstract][Full Text] [Related]
40. Initial diagnosis of chronic myelogenous leukemia based on quantification of M-BCR status using droplet digital PCR.
Lund HL; Hughesman CB; McNeil K; Clemens S; Hocken K; Pettersson R; Karsan A; Foster LJ; Haynes C
Anal Bioanal Chem; 2016 Feb; 408(4):1079-94. PubMed ID: 26631023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]